DNA-Sequencing of Baseline and Progression Plasma from the Phase III Alliance A031201 Trial

AFFECTION_STATUS - Case control status of the subject for metastatic castration-resistant prostate cancer (mCRPC); all subjects are mCRPC patients. (phv00535250.v2.p1)

ANALYTE_TYPE - Type of analyte used for analysis (phv00535257.v2.p1)
BODY_SITE - Sample was taken from this body site (phv00535256.v2.p1)
COLLECTION_TIMEPOINT - The timepoint for sample collection (phv00559033.v1.p1)
CONSENT - Consent group as determined by NIH Data Use Limitations (phv00535245.v2.p1)
HISTOLOGICAL_TYPE - Histological typing of primary tumor (phv00535259.v2.p1)
IS_TUMOR - Was the sample taken from an individual with a tumor (phv00535258.v2.p1)
SAMPLE_ID - Sample ID (phv00535254.v2.p1)
SAMPLE_ID - Sample ID (phv00535248.v2.p1)
SEQUENCING_BATCH - Sequencing plate ID (phv00535255.v2.p1)
SUBJECT_ID - Subject ID (phv00535244.v2.p1)
SUBJECT_ID - Subject ID (phv00535247.v2.p1)
SUBJECT_ID - Subject ID (phv00535249.v2.p1)